Table of Content

1 Study Coverage
1.1 Impotence Agents Product Introduction
1.2 Market by Type
1.2.1 Global Impotence Agents Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Oral Preparation
1.2.3 Injection
1.2.4 Other
1.3 Market by Application
1.3.1 Global Impotence Agents Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Erectile Dysfunction
1.3.3 Premature Ejaculation
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Impotence Agents Sales Estimates and Forecasts 2018-2029
2.2 Global Impotence Agents Revenue by Region
2.2.1 Global Impotence Agents Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Impotence Agents Revenue by Region (2018-2024)
2.2.3 Global Impotence Agents Revenue by Region (2024-2029)
2.2.4 Global Impotence Agents Revenue Market Share by Region (2018-2029)
2.3 Global Impotence Agents Sales Estimates and Forecasts 2018-2029
2.4 Global Impotence Agents Sales by Region
2.4.1 Global Impotence Agents Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Impotence Agents Sales by Region (2018-2024)
2.4.3 Global Impotence Agents Sales by Region (2024-2029)
2.4.4 Global Impotence Agents Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Impotence Agents Sales by Manufacturers
3.1.1 Global Impotence Agents Sales by Manufacturers (2018-2024)
3.1.2 Global Impotence Agents Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Impotence Agents in 2022
3.2 Global Impotence Agents Revenue by Manufacturers
3.2.1 Global Impotence Agents Revenue by Manufacturers (2018-2024)
3.2.2 Global Impotence Agents Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Impotence Agents Revenue in 2022
3.3 Global Key Players of Impotence Agents, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Impotence Agents Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Impotence Agents Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Impotence Agents, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Impotence Agents, Product Offered and Application
3.8 Global Key Manufacturers of Impotence Agents, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Impotence Agents Sales by Type
4.1.1 Global Impotence Agents Historical Sales by Type (2018-2024)
4.1.2 Global Impotence Agents Forecasted Sales by Type (2024-2029)
4.1.3 Global Impotence Agents Sales Market Share by Type (2018-2029)
4.2 Global Impotence Agents Revenue by Type
4.2.1 Global Impotence Agents Historical Revenue by Type (2018-2024)
4.2.2 Global Impotence Agents Forecasted Revenue by Type (2024-2029)
4.2.3 Global Impotence Agents Revenue Market Share by Type (2018-2029)
4.3 Global Impotence Agents Price by Type
4.3.1 Global Impotence Agents Price by Type (2018-2024)
4.3.2 Global Impotence Agents Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Impotence Agents Sales by Application
5.1.1 Global Impotence Agents Historical Sales by Application (2018-2024)
5.1.2 Global Impotence Agents Forecasted Sales by Application (2024-2029)
5.1.3 Global Impotence Agents Sales Market Share by Application (2018-2029)
5.2 Global Impotence Agents Revenue by Application
5.2.1 Global Impotence Agents Historical Revenue by Application (2018-2024)
5.2.2 Global Impotence Agents Forecasted Revenue by Application (2024-2029)
5.2.3 Global Impotence Agents Revenue Market Share by Application (2018-2029)
5.3 Global Impotence Agents Price by Application
5.3.1 Global Impotence Agents Price by Application (2018-2024)
5.3.2 Global Impotence Agents Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Impotence Agents Market Size by Type
6.1.1 US & Canada Impotence Agents Sales by Type (2018-2029)
6.1.2 US & Canada Impotence Agents Revenue by Type (2018-2029)
6.2 US & Canada Impotence Agents Market Size by Application
6.2.1 US & Canada Impotence Agents Sales by Application (2018-2029)
6.2.2 US & Canada Impotence Agents Revenue by Application (2018-2029)
6.3 US & Canada Impotence Agents Market Size by Country
6.3.1 US & Canada Impotence Agents Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Impotence Agents Sales by Country (2018-2029)
6.3.3 US & Canada Impotence Agents Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Impotence Agents Market Size by Type
7.1.1 Europe Impotence Agents Sales by Type (2018-2029)
7.1.2 Europe Impotence Agents Revenue by Type (2018-2029)
7.2 Europe Impotence Agents Market Size by Application
7.2.1 Europe Impotence Agents Sales by Application (2018-2029)
7.2.2 Europe Impotence Agents Revenue by Application (2018-2029)
7.3 Europe Impotence Agents Market Size by Country
7.3.1 Europe Impotence Agents Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Impotence Agents Sales by Country (2018-2029)
7.3.3 Europe Impotence Agents Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Impotence Agents Market Size
8.1.1 China Impotence Agents Sales (2018-2029)
8.1.2 China Impotence Agents Revenue (2018-2029)
8.2 China Impotence Agents Market Size by Application
8.2.1 China Impotence Agents Sales by Application (2018-2029)
8.2.2 China Impotence Agents Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Impotence Agents Market Size by Type
9.1.1 Asia Impotence Agents Sales by Type (2018-2029)
9.1.2 Asia Impotence Agents Revenue by Type (2018-2029)
9.2 Asia Impotence Agents Market Size by Application
9.2.1 Asia Impotence Agents Sales by Application (2018-2029)
9.2.2 Asia Impotence Agents Revenue by Application (2018-2029)
9.3 Asia Impotence Agents Sales by Region
9.3.1 Asia Impotence Agents Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Impotence Agents Revenue by Region (2018-2029)
9.3.3 Asia Impotence Agents Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Impotence Agents Market Size by Type
10.1.1 Middle East, Africa and Latin America Impotence Agents Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Impotence Agents Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Impotence Agents Market Size by Application
10.2.1 Middle East, Africa and Latin America Impotence Agents Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Impotence Agents Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Impotence Agents Sales by Country
10.3.1 Middle East, Africa and Latin America Impotence Agents Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Impotence Agents Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Impotence Agents Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Pfizer Inc
11.1.1 Pfizer Inc Company Information
11.1.2 Pfizer Inc Overview
11.1.3 Pfizer Inc Impotence Agents Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Pfizer Inc Impotence Agents Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Pfizer Inc Recent Developments
11.2 Bayer AG
11.2.1 Bayer AG Company Information
11.2.2 Bayer AG Overview
11.2.3 Bayer AG Impotence Agents Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Bayer AG Impotence Agents Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Bayer AG Recent Developments
11.3 Novartis AG
11.3.1 Novartis AG Company Information
11.3.2 Novartis AG Overview
11.3.3 Novartis AG Impotence Agents Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Novartis AG Impotence Agents Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Novartis AG Recent Developments
11.4 Hikma Pharmaceuticals plc
11.4.1 Hikma Pharmaceuticals plc Company Information
11.4.2 Hikma Pharmaceuticals plc Overview
11.4.3 Hikma Pharmaceuticals plc Impotence Agents Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Hikma Pharmaceuticals plc Impotence Agents Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Hikma Pharmaceuticals plc Recent Developments
11.5 Aurobindo Pharma
11.5.1 Aurobindo Pharma Company Information
11.5.2 Aurobindo Pharma Overview
11.5.3 Aurobindo Pharma Impotence Agents Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Aurobindo Pharma Impotence Agents Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Aurobindo Pharma Recent Developments
11.6 VIVUS LLC.
11.6.1 VIVUS LLC. Company Information
11.6.2 VIVUS LLC. Overview
11.6.3 VIVUS LLC. Impotence Agents Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 VIVUS LLC. Impotence Agents Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 VIVUS LLC. Recent Developments
11.7 Petros Pharmaceuticals, Inc.
11.7.1 Petros Pharmaceuticals, Inc. Company Information
11.7.2 Petros Pharmaceuticals, Inc. Overview
11.7.3 Petros Pharmaceuticals, Inc. Impotence Agents Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 Petros Pharmaceuticals, Inc. Impotence Agents Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Petros Pharmaceuticals, Inc. Recent Developments
11.8 Bristol-Myers Squibb Company
11.8.1 Bristol-Myers Squibb Company Company Information
11.8.2 Bristol-Myers Squibb Company Overview
11.8.3 Bristol-Myers Squibb Company Impotence Agents Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 Bristol-Myers Squibb Company Impotence Agents Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Bristol-Myers Squibb Company Recent Developments
11.9 GSK PLC
11.9.1 GSK PLC Company Information
11.9.2 GSK PLC Overview
11.9.3 GSK PLC Impotence Agents Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 GSK PLC Impotence Agents Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 GSK PLC Recent Developments
11.10 Sanofi
11.10.1 Sanofi Company Information
11.10.2 Sanofi Overview
11.10.3 Sanofi Impotence Agents Sales, Price, Revenue and Gross Margin (2018-2024)
11.10.4 Sanofi Impotence Agents Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Sanofi Recent Developments
11.11 Teva Pharmaceuticals Industries Ltd
11.11.1 Teva Pharmaceuticals Industries Ltd Company Information
11.11.2 Teva Pharmaceuticals Industries Ltd Overview
11.11.3 Teva Pharmaceuticals Industries Ltd Impotence Agents Sales, Price, Revenue and Gross Margin (2018-2024)
11.11.4 Teva Pharmaceuticals Industries Ltd Impotence Agents Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Teva Pharmaceuticals Industries Ltd Recent Developments
11.12 Lilly
11.12.1 Lilly Company Information
11.12.2 Lilly Overview
11.12.3 Lilly Impotence Agents Sales, Price, Revenue and Gross Margin (2018-2024)
11.12.4 Lilly Impotence Agents Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Lilly Recent Developments
11.13 Adamed
11.13.1 Adamed Company Information
11.13.2 Adamed Overview
11.13.3 Adamed Impotence Agents Sales, Price, Revenue and Gross Margin (2018-2024)
11.13.4 Adamed Impotence Agents Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Adamed Recent Developments
11.14 Sun Pharmaceutical Industries, Ltd.
11.14.1 Sun Pharmaceutical Industries, Ltd. Company Information
11.14.2 Sun Pharmaceutical Industries, Ltd. Overview
11.14.3 Sun Pharmaceutical Industries, Ltd. Impotence Agents Sales, Price, Revenue and Gross Margin (2018-2024)
11.14.4 Sun Pharmaceutical Industries, Ltd. Impotence Agents Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Sun Pharmaceutical Industries, Ltd. Recent Developments
11.15 Auxilium Pharmaceuticals, Inc.
11.15.1 Auxilium Pharmaceuticals, Inc. Company Information
11.15.2 Auxilium Pharmaceuticals, Inc. Overview
11.15.3 Auxilium Pharmaceuticals, Inc. Impotence Agents Sales, Price, Revenue and Gross Margin (2018-2024)
11.15.4 Auxilium Pharmaceuticals, Inc. Impotence Agents Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Auxilium Pharmaceuticals, Inc. Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Impotence Agents Industry Chain Analysis
12.2 Impotence Agents Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Impotence Agents Production Mode & Process
12.4 Impotence Agents Sales and Marketing
12.4.1 Impotence Agents Sales Channels
12.4.2 Impotence Agents Distributors
12.5 Impotence Agents Customers
13 Market Dynamics
13.1 Impotence Agents Industry Trends
13.2 Impotence Agents Market Drivers
13.3 Impotence Agents Market Challenges
13.4 Impotence Agents Market Restraints
14 Key Findings in The Global Impotence Agents Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Impotence Agents Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Oral Preparation
Table 3. Major Manufacturers of Injection
Table 4. Major Manufacturers of Other
Table 5. Global Impotence Agents Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Impotence Agents Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 7. Global Impotence Agents Revenue by Region (2018-2024) & (US$ Million)
Table 8. Global Impotence Agents Revenue by Region (2024-2029) & (US$ Million)
Table 9. Global Impotence Agents Revenue Market Share by Region (2018-2024)
Table 10. Global Impotence Agents Revenue Market Share by Region (2024-2029)
Table 11. Global Impotence Agents Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 12. Global Impotence Agents Sales by Region (2018-2024) & (K Units)
Table 13. Global Impotence Agents Sales by Region (2024-2029) & (K Units)
Table 14. Global Impotence Agents Sales Market Share by Region (2018-2024)
Table 15. Global Impotence Agents Sales Market Share by Region (2024-2029)
Table 16. Global Impotence Agents Sales by Manufacturers (2018-2024) & (K Units)
Table 17. Global Impotence Agents Sales Share by Manufacturers (2018-2024)
Table 18. Global Impotence Agents Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 19. Global Impotence Agents Revenue Share by Manufacturers (2018-2024)
Table 20. Global Key Players of Impotence Agents, Industry Ranking, 2021 VS 2022 VS 2024
Table 21. Impotence Agents Price by Manufacturers 2018-2024 (US$/Unit)
Table 22. Global Impotence Agents Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 23. Global Impotence Agents by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Impotence Agents as of 2022)
Table 24. Global Key Manufacturers of Impotence Agents, Manufacturing Base Distribution and Headquarters
Table 25. Global Key Manufacturers of Impotence Agents, Product Offered and Application
Table 26. Global Key Manufacturers of Impotence Agents, Date of Enter into This Industry
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Impotence Agents Sales by Type (2018-2024) & (K Units)
Table 29. Global Impotence Agents Sales by Type (2024-2029) & (K Units)
Table 30. Global Impotence Agents Sales Share by Type (2018-2024)
Table 31. Global Impotence Agents Sales Share by Type (2024-2029)
Table 32. Global Impotence Agents Revenue by Type (2018-2024) & (US$ Million)
Table 33. Global Impotence Agents Revenue by Type (2024-2029) & (US$ Million)
Table 34. Global Impotence Agents Revenue Share by Type (2018-2024)
Table 35. Global Impotence Agents Revenue Share by Type (2024-2029)
Table 36. Impotence Agents Price by Type (2018-2024) & (US$/Unit)
Table 37. Global Impotence Agents Price Forecast by Type (2024-2029) & (US$/Unit)
Table 38. Global Impotence Agents Sales by Application (2018-2024) & (K Units)
Table 39. Global Impotence Agents Sales by Application (2024-2029) & (K Units)
Table 40. Global Impotence Agents Sales Share by Application (2018-2024)
Table 41. Global Impotence Agents Sales Share by Application (2024-2029)
Table 42. Global Impotence Agents Revenue by Application (2018-2024) & (US$ Million)
Table 43. Global Impotence Agents Revenue by Application (2024-2029) & (US$ Million)
Table 44. Global Impotence Agents Revenue Share by Application (2018-2024)
Table 45. Global Impotence Agents Revenue Share by Application (2024-2029)
Table 46. Impotence Agents Price by Application (2018-2024) & (US$/Unit)
Table 47. Global Impotence Agents Price Forecast by Application (2024-2029) & (US$/Unit)
Table 48. US & Canada Impotence Agents Sales by Type (2018-2024) & (K Units)
Table 49. US & Canada Impotence Agents Sales by Type (2024-2029) & (K Units)
Table 50. US & Canada Impotence Agents Revenue by Type (2018-2024) & (US$ Million)
Table 51. US & Canada Impotence Agents Revenue by Type (2024-2029) & (US$ Million)
Table 52. US & Canada Impotence Agents Sales by Application (2018-2024) & (K Units)
Table 53. US & Canada Impotence Agents Sales by Application (2024-2029) & (K Units)
Table 54. US & Canada Impotence Agents Revenue by Application (2018-2024) & (US$ Million)
Table 55. US & Canada Impotence Agents Revenue by Application (2024-2029) & (US$ Million)
Table 56. US & Canada Impotence Agents Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 57. US & Canada Impotence Agents Revenue by Country (2018-2024) & (US$ Million)
Table 58. US & Canada Impotence Agents Revenue by Country (2024-2029) & (US$ Million)
Table 59. US & Canada Impotence Agents Sales by Country (2018-2024) & (K Units)
Table 60. US & Canada Impotence Agents Sales by Country (2024-2029) & (K Units)
Table 61. Europe Impotence Agents Sales by Type (2018-2024) & (K Units)
Table 62. Europe Impotence Agents Sales by Type (2024-2029) & (K Units)
Table 63. Europe Impotence Agents Revenue by Type (2018-2024) & (US$ Million)
Table 64. Europe Impotence Agents Revenue by Type (2024-2029) & (US$ Million)
Table 65. Europe Impotence Agents Sales by Application (2018-2024) & (K Units)
Table 66. Europe Impotence Agents Sales by Application (2024-2029) & (K Units)
Table 67. Europe Impotence Agents Revenue by Application (2018-2024) & (US$ Million)
Table 68. Europe Impotence Agents Revenue by Application (2024-2029) & (US$ Million)
Table 69. Europe Impotence Agents Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 70. Europe Impotence Agents Revenue by Country (2018-2024) & (US$ Million)
Table 71. Europe Impotence Agents Revenue by Country (2024-2029) & (US$ Million)
Table 72. Europe Impotence Agents Sales by Country (2018-2024) & (K Units)
Table 73. Europe Impotence Agents Sales by Country (2024-2029) & (K Units)
Table 74. China Impotence Agents Sales by Type (2018-2024) & (K Units)
Table 75. China Impotence Agents Sales by Type (2024-2029) & (K Units)
Table 76. China Impotence Agents Revenue by Type (2018-2024) & (US$ Million)
Table 77. China Impotence Agents Revenue by Type (2024-2029) & (US$ Million)
Table 78. China Impotence Agents Sales by Application (2018-2024) & (K Units)
Table 79. China Impotence Agents Sales by Application (2024-2029) & (K Units)
Table 80. China Impotence Agents Revenue by Application (2018-2024) & (US$ Million)
Table 81. China Impotence Agents Revenue by Application (2024-2029) & (US$ Million)
Table 82. Asia Impotence Agents Sales by Type (2018-2024) & (K Units)
Table 83. Asia Impotence Agents Sales by Type (2024-2029) & (K Units)
Table 84. Asia Impotence Agents Revenue by Type (2018-2024) & (US$ Million)
Table 85. Asia Impotence Agents Revenue by Type (2024-2029) & (US$ Million)
Table 86. Asia Impotence Agents Sales by Application (2018-2024) & (K Units)
Table 87. Asia Impotence Agents Sales by Application (2024-2029) & (K Units)
Table 88. Asia Impotence Agents Revenue by Application (2018-2024) & (US$ Million)
Table 89. Asia Impotence Agents Revenue by Application (2024-2029) & (US$ Million)
Table 90. Asia Impotence Agents Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 91. Asia Impotence Agents Revenue by Region (2018-2024) & (US$ Million)
Table 92. Asia Impotence Agents Revenue by Region (2024-2029) & (US$ Million)
Table 93. Asia Impotence Agents Sales by Region (2018-2024) & (K Units)
Table 94. Asia Impotence Agents Sales by Region (2024-2029) & (K Units)
Table 95. Middle East, Africa and Latin America Impotence Agents Sales by Type (2018-2024) & (K Units)
Table 96. Middle East, Africa and Latin America Impotence Agents Sales by Type (2024-2029) & (K Units)
Table 97. Middle East, Africa and Latin America Impotence Agents Revenue by Type (2018-2024) & (US$ Million)
Table 98. Middle East, Africa and Latin America Impotence Agents Revenue by Type (2024-2029) & (US$ Million)
Table 99. Middle East, Africa and Latin America Impotence Agents Sales by Application (2018-2024) & (K Units)
Table 100. Middle East, Africa and Latin America Impotence Agents Sales by Application (2024-2029) & (K Units)
Table 101. Middle East, Africa and Latin America Impotence Agents Revenue by Application (2018-2024) & (US$ Million)
Table 102. Middle East, Africa and Latin America Impotence Agents Revenue by Application (2024-2029) & (US$ Million)
Table 103. Middle East, Africa and Latin America Impotence Agents Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 104. Middle East, Africa and Latin America Impotence Agents Revenue by Country (2018-2024) & (US$ Million)
Table 105. Middle East, Africa and Latin America Impotence Agents Revenue by Country (2024-2029) & (US$ Million)
Table 106. Middle East, Africa and Latin America Impotence Agents Sales by Country (2018-2024) & (K Units)
Table 107. Middle East, Africa and Latin America Impotence Agents Sales by Country (2024-2029) & (K Units)
Table 108. Pfizer Inc Company Information
Table 109. Pfizer Inc Description and Major Businesses
Table 110. Pfizer Inc Impotence Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 111. Pfizer Inc Impotence Agents Product Model Numbers, Pictures, Descriptions and Specifications
Table 112. Pfizer Inc Recent Developments
Table 113. Bayer AG Company Information
Table 114. Bayer AG Description and Major Businesses
Table 115. Bayer AG Impotence Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 116. Bayer AG Impotence Agents Product Model Numbers, Pictures, Descriptions and Specifications
Table 117. Bayer AG Recent Developments
Table 118. Novartis AG Company Information
Table 119. Novartis AG Description and Major Businesses
Table 120. Novartis AG Impotence Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 121. Novartis AG Impotence Agents Product Model Numbers, Pictures, Descriptions and Specifications
Table 122. Novartis AG Recent Developments
Table 123. Hikma Pharmaceuticals plc Company Information
Table 124. Hikma Pharmaceuticals plc Description and Major Businesses
Table 125. Hikma Pharmaceuticals plc Impotence Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 126. Hikma Pharmaceuticals plc Impotence Agents Product Model Numbers, Pictures, Descriptions and Specifications
Table 127. Hikma Pharmaceuticals plc Recent Developments
Table 128. Aurobindo Pharma Company Information
Table 129. Aurobindo Pharma Description and Major Businesses
Table 130. Aurobindo Pharma Impotence Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 131. Aurobindo Pharma Impotence Agents Product Model Numbers, Pictures, Descriptions and Specifications
Table 132. Aurobindo Pharma Recent Developments
Table 133. VIVUS LLC. Company Information
Table 134. VIVUS LLC. Description and Major Businesses
Table 135. VIVUS LLC. Impotence Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 136. VIVUS LLC. Impotence Agents Product Model Numbers, Pictures, Descriptions and Specifications
Table 137. VIVUS LLC. Recent Developments
Table 138. Petros Pharmaceuticals, Inc. Company Information
Table 139. Petros Pharmaceuticals, Inc. Description and Major Businesses
Table 140. Petros Pharmaceuticals, Inc. Impotence Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 141. Petros Pharmaceuticals, Inc. Impotence Agents Product Model Numbers, Pictures, Descriptions and Specifications
Table 142. Petros Pharmaceuticals, Inc. Recent Developments
Table 143. Bristol-Myers Squibb Company Company Information
Table 144. Bristol-Myers Squibb Company Description and Major Businesses
Table 145. Bristol-Myers Squibb Company Impotence Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 146. Bristol-Myers Squibb Company Impotence Agents Product Model Numbers, Pictures, Descriptions and Specifications
Table 147. Bristol-Myers Squibb Company Recent Developments
Table 148. GSK PLC Company Information
Table 149. GSK PLC Description and Major Businesses
Table 150. GSK PLC Impotence Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 151. GSK PLC Impotence Agents Product Model Numbers, Pictures, Descriptions and Specifications
Table 152. GSK PLC Recent Developments
Table 153. Sanofi Company Information
Table 154. Sanofi Description and Major Businesses
Table 155. Sanofi Impotence Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 156. Sanofi Impotence Agents Product Model Numbers, Pictures, Descriptions and Specifications
Table 157. Sanofi Recent Developments
Table 158. Teva Pharmaceuticals Industries Ltd Company Information
Table 159. Teva Pharmaceuticals Industries Ltd Description and Major Businesses
Table 160. Teva Pharmaceuticals Industries Ltd Impotence Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 161. Teva Pharmaceuticals Industries Ltd Impotence Agents Product Model Numbers, Pictures, Descriptions and Specifications
Table 162. Teva Pharmaceuticals Industries Ltd Recent Developments
Table 163. Lilly Company Information
Table 164. Lilly Description and Major Businesses
Table 165. Lilly Impotence Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 166. Lilly Impotence Agents Product Model Numbers, Pictures, Descriptions and Specifications
Table 167. Lilly Recent Developments
Table 168. Adamed Company Information
Table 169. Adamed Description and Major Businesses
Table 170. Adamed Impotence Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 171. Adamed Impotence Agents Product Model Numbers, Pictures, Descriptions and Specifications
Table 172. Adamed Recent Developments
Table 173. Sun Pharmaceutical Industries, Ltd. Company Information
Table 174. Sun Pharmaceutical Industries, Ltd. Description and Major Businesses
Table 175. Sun Pharmaceutical Industries, Ltd. Impotence Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 176. Sun Pharmaceutical Industries, Ltd. Impotence Agents Product Model Numbers, Pictures, Descriptions and Specifications
Table 177. Sun Pharmaceutical Industries, Ltd. Recent Developments
Table 178. Auxilium Pharmaceuticals, Inc. Company Information
Table 179. Auxilium Pharmaceuticals, Inc. Description and Major Businesses
Table 180. Auxilium Pharmaceuticals, Inc. Impotence Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 181. Auxilium Pharmaceuticals, Inc. Impotence Agents Product Model Numbers, Pictures, Descriptions and Specifications
Table 182. Auxilium Pharmaceuticals, Inc. Recent Developments
Table 183. Key Raw Materials Lists
Table 184. Raw Materials Key Suppliers Lists
Table 185. Impotence Agents Distributors List
Table 186. Impotence Agents Customers List
Table 187. Impotence Agents Market Trends
Table 188. Impotence Agents Market Drivers
Table 189. Impotence Agents Market Challenges
Table 190. Impotence Agents Market Restraints
Table 191. Research Programs/Design for This Report
Table 192. Key Data Information from Secondary Sources
Table 193. Key Data Information from Primary Sources
List of Figures
Figure 1. Impotence Agents Product Picture
Figure 2. Global Impotence Agents Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Impotence Agents Market Share by Type in 2022 & 2029
Figure 4. Oral Preparation Product Picture
Figure 5. Injection Product Picture
Figure 6. Other Product Picture
Figure 7. Global Impotence Agents Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 8. Global Impotence Agents Market Share by Application in 2022 & 2029
Figure 9. Erectile Dysfunction
Figure 10. Premature Ejaculation
Figure 11. Other
Figure 12. Impotence Agents Report Years Considered
Figure 13. Global Impotence Agents Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Impotence Agents Revenue 2018-2029 (US$ Million)
Figure 15. Global Impotence Agents Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 16. Global Impotence Agents Revenue Market Share by Region (2018-2029)
Figure 17. Global Impotence Agents Sales 2018-2029 ((K Units)
Figure 18. Global Impotence Agents Sales Market Share by Region (2018-2029)
Figure 19. US & Canada Impotence Agents Sales YoY (2018-2029) & (K Units)
Figure 20. US & Canada Impotence Agents Revenue YoY (2018-2029) & (US$ Million)
Figure 21. Europe Impotence Agents Sales YoY (2018-2029) & (K Units)
Figure 22. Europe Impotence Agents Revenue YoY (2018-2029) & (US$ Million)
Figure 23. China Impotence Agents Sales YoY (2018-2029) & (K Units)
Figure 24. China Impotence Agents Revenue YoY (2018-2029) & (US$ Million)
Figure 25. Asia (excluding China) Impotence Agents Sales YoY (2018-2029) & (K Units)
Figure 26. Asia (excluding China) Impotence Agents Revenue YoY (2018-2029) & (US$ Million)
Figure 27. Middle East, Africa and Latin America Impotence Agents Sales YoY (2018-2029) & (K Units)
Figure 28. Middle East, Africa and Latin America Impotence Agents Revenue YoY (2018-2029) & (US$ Million)
Figure 29. The Impotence Agents Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 30. The Top 5 and 10 Largest Manufacturers of Impotence Agents in the World: Market Share by Impotence Agents Revenue in 2022
Figure 31. Global Impotence Agents Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 32. Global Impotence Agents Sales Market Share by Type (2018-2029)
Figure 33. Global Impotence Agents Revenue Market Share by Type (2018-2029)
Figure 34. Global Impotence Agents Sales Market Share by Application (2018-2029)
Figure 35. Global Impotence Agents Revenue Market Share by Application (2018-2029)
Figure 36. US & Canada Impotence Agents Sales Market Share by Type (2018-2029)
Figure 37. US & Canada Impotence Agents Revenue Market Share by Type (2018-2029)
Figure 38. US & Canada Impotence Agents Sales Market Share by Application (2018-2029)
Figure 39. US & Canada Impotence Agents Revenue Market Share by Application (2018-2029)
Figure 40. US & Canada Impotence Agents Revenue Share by Country (2018-2029)
Figure 41. US & Canada Impotence Agents Sales Share by Country (2018-2029)
Figure 42. U.S. Impotence Agents Revenue (2018-2029) & (US$ Million)
Figure 43. Canada Impotence Agents Revenue (2018-2029) & (US$ Million)
Figure 44. Europe Impotence Agents Sales Market Share by Type (2018-2029)
Figure 45. Europe Impotence Agents Revenue Market Share by Type (2018-2029)
Figure 46. Europe Impotence Agents Sales Market Share by Application (2018-2029)
Figure 47. Europe Impotence Agents Revenue Market Share by Application (2018-2029)
Figure 48. Europe Impotence Agents Revenue Share by Country (2018-2029)
Figure 49. Europe Impotence Agents Sales Share by Country (2018-2029)
Figure 50. Germany Impotence Agents Revenue (2018-2029) & (US$ Million)
Figure 51. France Impotence Agents Revenue (2018-2029) & (US$ Million)
Figure 52. U.K. Impotence Agents Revenue (2018-2029) & (US$ Million)
Figure 53. Italy Impotence Agents Revenue (2018-2029) & (US$ Million)
Figure 54. Russia Impotence Agents Revenue (2018-2029) & (US$ Million)
Figure 55. China Impotence Agents Sales Market Share by Type (2018-2029)
Figure 56. China Impotence Agents Revenue Market Share by Type (2018-2029)
Figure 57. China Impotence Agents Sales Market Share by Application (2018-2029)
Figure 58. China Impotence Agents Revenue Market Share by Application (2018-2029)
Figure 59. Asia Impotence Agents Sales Market Share by Type (2018-2029)
Figure 60. Asia Impotence Agents Revenue Market Share by Type (2018-2029)
Figure 61. Asia Impotence Agents Sales Market Share by Application (2018-2029)
Figure 62. Asia Impotence Agents Revenue Market Share by Application (2018-2029)
Figure 63. Asia Impotence Agents Revenue Share by Region (2018-2029)
Figure 64. Asia Impotence Agents Sales Share by Region (2018-2029)
Figure 65. Japan Impotence Agents Revenue (2018-2029) & (US$ Million)
Figure 66. South Korea Impotence Agents Revenue (2018-2029) & (US$ Million)
Figure 67. China Taiwan Impotence Agents Revenue (2018-2029) & (US$ Million)
Figure 68. Southeast Asia Impotence Agents Revenue (2018-2029) & (US$ Million)
Figure 69. India Impotence Agents Revenue (2018-2029) & (US$ Million)
Figure 70. Middle East, Africa and Latin America Impotence Agents Sales Market Share by Type (2018-2029)
Figure 71. Middle East, Africa and Latin America Impotence Agents Revenue Market Share by Type (2018-2029)
Figure 72. Middle East, Africa and Latin America Impotence Agents Sales Market Share by Application (2018-2029)
Figure 73. Middle East, Africa and Latin America Impotence Agents Revenue Market Share by Application (2018-2029)
Figure 74. Middle East, Africa and Latin America Impotence Agents Revenue Share by Country (2018-2029)
Figure 75. Middle East, Africa and Latin America Impotence Agents Sales Share by Country (2018-2029)
Figure 76. Brazil Impotence Agents Revenue (2018-2029) & (US$ Million)
Figure 77. Mexico Impotence Agents Revenue (2018-2029) & (US$ Million)
Figure 78. Turkey Impotence Agents Revenue (2018-2029) & (US$ Million)
Figure 79. Israel Impotence Agents Revenue (2018-2029) & (US$ Million)
Figure 80. GCC Countries Impotence Agents Revenue (2018-2029) & (US$ Million)
Figure 81. Impotence Agents Value Chain
Figure 82. Impotence Agents Production Process
Figure 83. Channels of Distribution
Figure 84. Distributors Profiles
Figure 85. Bottom-up and Top-down Approaches for This Report
Figure 86. Data Triangulation
Figure 87. Key Executives Interviewed